Literature DB >> 12034711

Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization.

Nicolai Sidenius1, Annapaola Andolfo, Riccardo Fesce, Francesco Blasi.   

Abstract

Adhesion of monocytes to the extracellular matrix is mediated by a direct high affinity interaction between cell-surface urokinase-type plasminogen activator (uPA) receptor (uPAR) and the extracellular matrix protein vitronectin. We demonstrate a tight connection between uPA-regulated uPAR oligomerization and high affinity binding to immobilized vitronectin. We find that binding of soluble uPAR (suPAR) to immobilized vitronectin is strictly ligand-dependent with a linear relationship between the observed binding and the concentration of ligand added. Nevertheless, a comparison of experimentally obtained binding curves to those generated using a simple equilibrium model suggests that the high affinity vitronectin-binding pro-uPA.suPAR complex contains two molecules of suPAR. In co-immunoprecipitation experiments, using different epitope-tagged suPAR molecules, suPAR/suPAR co-immunoprecipitation displayed a similar uPA dose dependence as that observed for vitronectin binding, demonstrating that the high affinity vitronectin-binding complex indeed contains oligomeric suPAR. Structurally, the kringle domain of uPA was found to be critical for the formation of the vitronectin-binding competent complex because the amino-terminal fragment, but not the growth factor-like domain, behaved as a full-length uPA. Our data represent the first demonstration of functional, ligand-induced uPAR oligomerization having extensive implications for glycosylphosphatidylinositol-anchored receptors in general, and for the biology of the uPA/uPAR system in particular.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034711     DOI: 10.1074/jbc.M111736200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Structural basis of interaction between urokinase-type plasminogen activator and its receptor.

Authors:  Cyril Barinka; Graham Parry; Jennifer Callahan; David E Shaw; Alice Kuo; Khalil Bdeir; Douglas B Cines; Andrew Mazar; Jacek Lubkowski
Journal:  J Mol Biol       Date:  2006-08-26       Impact factor: 5.469

2.  A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogen.

Authors:  Boryana M Eastman; Minji Jo; Drue L Webb; Shinako Takimoto; Steven L Gonias
Journal:  Cell Signal       Date:  2012-05-19       Impact factor: 4.315

3.  Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes.

Authors:  Qing Huai; Aiwu Zhou; Lin Lin; Andrew P Mazar; Graham C Parry; Jennifer Callahan; David E Shaw; Bruce Furie; Barbara C Furie; Mingdong Huang
Journal:  Nat Struct Mol Biol       Date:  2008-03-23       Impact factor: 15.369

4.  The vitronectin RGD motif regulates TGF-β-induced alveolar epithelial cell apoptosis.

Authors:  Amanda K Wheaton; Miranda Velikoff; Manisha Agarwal; Tiffany T Loo; Jeffrey C Horowitz; Thomas H Sisson; Kevin K Kim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-04-22       Impact factor: 5.464

Review 5.  Regulation of cell signalling by uPAR.

Authors:  Harvey W Smith; Chris J Marshall
Journal:  Nat Rev Mol Cell Biol       Date:  2010-01       Impact factor: 94.444

6.  Conformational regulation of urokinase receptor function: impact of receptor occupancy and epitope-mapped monoclonal antibodies on lamellipodia induction.

Authors:  Henrik Gårdsvoll; Benedikte Jacobsen; Mette C Kriegbaum; Niels Behrendt; Lars Engelholm; Søren Østergaard; Michael Ploug
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

7.  A deletion mutant of vitronectin lacking the somatomedin B domain exhibits residual plasminogen activator inhibitor-1-binding activity.

Authors:  Christine R Schar; Grant E Blouse; Kenneth H Minor; Cynthia B Peterson
Journal:  J Biol Chem       Date:  2008-01-03       Impact factor: 5.157

8.  Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions.

Authors:  Orla Cunningham; Annapaola Andolfo; Maria Lisa Santovito; Lucia Iuzzolino; Francesco Blasi; Nicolai Sidenius
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

9.  SLURP-1 modulates corneal homeostasis by serving as a soluble scavenger of urokinase-type plasminogen activator.

Authors:  Sudha Swamynathan; Shivalingappa K Swamynathan
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-28       Impact factor: 4.799

10.  The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific endoproteolysis.

Authors:  Dominique Leduc; Nathalie Beaufort; Sophie de Bentzmann; Jean-Claude Rousselle; Abdelkader Namane; Michel Chignard; Dominique Pidard
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.